Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The role of reactive SH groups (presumably in proteins) of the apical plasma membrane in transepithelial Na+ transport was studied in the isolated urinary bladder of the toad. On the basis of assays for TCA-soluble SH compounds (e.g., glutathione, methionine), PCMB, PCMPS, NTCB, and DTNB did not penetrate the intracellular compartment from the luminal media either in control or
vasopressin
-treated bladders. In contrast, PCMB from the serosal side and NEM from the luminal side titrated significant fractions of the TCA-soluble SH compounds. We conclude, therefore, the PCMB, PCMPS, NTCB, and DTNB are suitable reagents for studies on the physiological properties of apical plasma membrane SH groups. Titration of apical membrane SH groups with PCMPS, NTCB, and DTNB revealed heterogeneity in functional responses: PCMPS and NTCB elicited transient, 25-60% increases in SCC. In substrate-free media, pretreatment with these reagents inhibited the increase in SCC produced by
vasopressin
or cyclic
AMP
(+ theophylline). In glucose-enriched media, the responses to combinations of
vasopressin
and PCMPS or NTCB were additive, implying activation via parallel pathways. Simultaneous addition of
vasopressin
or cyclic
AMP
(+ theophylline) and NTCB resulted in marked synergism, presumably as a result of unmasking of SH groups by the the hormone (or the intermediate). These results suggest that basal Na+ transport is regulated in part by SH compounds in the apical membrane that are distinct, although not necessarily different in kind, from those involved in the response to
vasopressin
.
...
PMID:Effects of sulfhydryl reagents on basal and vasopressin-stimulated Na+ transport in the toad bladder. 16 61
A
vasopressin
resistant urinary concentrating defect has been described in patients receiving lithium salt for affective disorders. For the pathogenic mechanism of the concentrating defect it has been postulated that lithium inhibits the
vasopressin
-dependent cyclic
AMP
system. However, the results of indirect studies on the lithium effect are equivocal. Therefore, the effect of lithium specifically on the
vasopressin
-dependent cyclic
AMP
system was investigated in rat renal medulla. The increase of cyclic
AMP
concentration by
vasopressin
was inhibited by lithium. But lithium had no effect on the PTH-dependent cyclic
AMP
concentration in renal cortical slices. Regardless of magnesium concentrations from 0-10 mM in the incubation media, 10 mM lithium had no moeasurable effect on the
vasopressin
-dependent adenylate cyclase of rat renal medulla. However, 10 mM lithium augmented the cyclic
AMP
-phosphodiesterase activity in renal medulla in the high Km system. These results suggest that lithium inhibits the
vasopressin
-dependent cyclic
AMP
concentration in renal medulla via the augmentation of its catabolism, rather than via the inhibition of cyclic
AMP
generation.
...
PMID:Effects of lithium on vasopressin-dependent cyclic AMP in rat renal medulla. 16 28
By use of an immunofluorescent cytochemical staining technique, adenosine 3',5'-monophosphate (cyclic
AMP
) has been localized in toad bladder epithelial cells. Within 2 minutes after addition of
vasopressin
, staining intensity increases in both mitochondria-rich and granular cells. This finding, taken together with the precise anatomical relation between these two epithelial cell types and the observation that after separation of the two cell types
vasopressin
stimulates cyclic
AMP
accumulation in only mitochondria-rich cells, suggests that cyclic
AMP
may be transferred from mitochrondria-rich to granular cells as part of the response of the toad urinary bladder to
vasopressin
.
...
PMID:Immunofluorescent localization of cyclic AMP in toad urinary bladder: possible intercellular transfer. 16 37
The influence of freshly purified ATP on the effects of aggregating agents on human platelets was studied. ATP inhibited aggregation induced by ADP competitively (Ki = 20 muM) and immediately without need for prior incubation. ATP had no effect on primary aggregation induced by adrenaline, thrombin,
vasopressin
, or 5-hydroxytryptamine (5HT). ATP inhibited the shape change and the consumption of metabolic ATP induced by ADP but did not inhibit these effects when induced by thrombin,
vasopressin
, or 5HT. ATP counteracted the inhibition by ADP of PGE1-stimulated cyclic
AMP
production in platelets but did not reduce inhibition by adrenaline. It is concluded that adrenaline, thrombin, 5HT, and
vasopressin
each can induce primary aggregation of human platelets by a mechanism independent of extracellular ADP.
...
PMID:The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. 16 88
1. Calcium did not influence the spontaneous release of
vasopressin
from rat neurohypophyses in vitro when used in concentrations of 0.05, 0.5 and 2.8 mM in the bathing medium. 2. Stimulation of the basal output of
vasopressin
by angiotensin II (1 X 10(-9) M) required at least 0.5 mM calcium in the medium. 3. Angiotensin II stimulated the release of
vasopressin
within 2.5 min of incubation, maximal release was observed after 10 min. 4. Angiotensin II rapidly promoted the accumulation of tissue cyclic
AMP
; maximal accumulation was observed after 5 min of incubation. 5. Theophylline and dibutyryl cyclic
AMP
produced varying degree of stimulation of the release of
vasopressin
. 6. Increases in
vasopressin
secretion and in the accumulation of cyclic
AMP
were always present when neurohypophyses were exposed to optiman concentrations of angiotensin II. The results presented suggested that cyclic
AMP
may be an intermediate step for the release of
vasopressin
by endogenous angiotensin II.
...
PMID:Stimulation by angiotensin II of the release of vasopressin from incubated rat neurohypophyses---possible involvement of cyclic AMP. 16 23
1. Angiotensin I, a decapeptide, stimulated the accumulation of cyclic 3',5'-AMP (cyclic
AMP
) and the release of
vasopressin
from incubated rat neurohypophyses. 2. Various octapeptides related to angiotensin II were capable of producing similar
neurohypophyseal
effects. 3. Longer incubation periods were needed with peptides having alterations or omission (e.g. heptapeptide 2-8) at position 1 of the parent molecule to evoke similar effects to those of angiotensin II. 4. Our results suggest strongly that physiological doses of angiotensin-related molecules stimulate the secretion of
vasopressin
through cyclic
AMP
, and that the
neurohypophyseal
receptor responsible for these effects is similar to that involved in their peripheral actions.
...
PMID:Structural requirements for angiotensin analogues to accumulate cyclic AMP and release vasopressin from the incubated rat neurohypophysis. 16 24
The effect of prostaglandin E1 (PGE1) on osmotic water flow across toad bladder and cyclic
AMP
content of the mucosal epithelial cells has been determined under basal conditions and in the presence of either theophylline or
antidiuretic hormone
(
ADH
); Under basal conditions and with PGE1 concentrations from 10(-8) to 10(-5) M no evidence of stimulation of water flow was observed, and with 10(-7) M PGE1 a significant inhibition was foundmcyclic
AMP
content under control conditions was 8 pmol/mg protein. It was 9 at 10(-8) M PGE1, 13 at 10(-7) M, 16 at 10(-6) M, and 23 at 10(-5) M. In the presence of theophylline, 10(-8) and 10(-7) M PGE1 inhibited the theophylline-induced water flow as expected. In contrast, 10(-6) and 10(-5) M PGE1 enhanced the rate of water flow. Theophylline increased cyclic
AMP
content from 8 to 18 pmol/mg protein. PGE1 in the presence of theophylline caused marked increases in cyclic
AMP
content; The content was 23 at 10(-7) M, 41 at 10(-6) M, and 130 at 10(-5) M; Thus PGE1 stimulates theophylline-induced water flow at cyclic
AMP
concentrations somewhere between 23 and 41 pmol/mg. Further evidence along these lines was obtained from experiments in which the effects of PGE1 on
ADH
-induced water flow were studied. Inhibitory effects of PGE1 were not observed at concentrations of PGE1 which raised the level of intracellular cyclic
AMP
to 30 pmol/mg protein or higher. These results were obtained despite the fact that all four concentrations of PGE1 tested were found capable of inhibiting
ADH
-induced water flow under appropriate conditions or, in other words, were inhibiting the adenylate cyclase controlling water flow, Thus the increase in cyclic
AMP
content in response to PGE1 is not derived from this enzyme. Thus the stimulation of water flow by PGE1 in the presence of theophylline is thought to be caused by cyclic
AMP
spilling over from one compartment to the water flow compartment. No evidence was obtained to directly suggest spillover into the sodium transport compartment. Furthermore evidence is discussed to suggest that most of the cyclic
AMP
generated in the tissue does not originate from the enzyme controlling sodium transport. As cyclic
AMP
-stimulated water flow and sodium transport are thought to occur in one cell type, the granular cells, distinct pools of cyclic
AMP
are thought to be present in one and the same cell type. Thus one pool controls water flow and one controls sodium transport. With high concentrations of PGE1 in the presence of theophylline or high concentrations of
ADH
, the adenylate cyclase responsible for water flow is inhibited; However, PGE1 can stimulate a tissue adenylate cyclase to sufficiently high levels that cyclic
AMP
spills over into the "water flow compartment" and thus stimulates water flow.
...
PMID:Stimulation of osmotic water flow in toad bladder by prostaglandin E1. Evidence for different compartments of cyclic AMP. 16 31
Lithium (Li+) chloride, 2 to 3 mEq. per kilogram of body weight, was administered intraperitoneally to normal Wistar rats daily for 4 to 66 days. This resulted in a marked reduction in urine osmolality (Uosm.) and increase in the excretion of water, Na+, K+, uric acid, and phosphate. The excretion of uric acid and potassium was a direct function of UNaV. The magnitude of depression in urine osmolality was significantly related to the rate of excretion of lithium in the urine, suggesting that the change in water reabsorption is dependent on the presence of the ion in the luminal side of the tubule. During 2 per cent saline diuresis, Li+-treated rats achieved less fractional free water reabsorption (TcH2O/GFR times 100) at any level of fractional osmolar clearance (Cosm./GFR times 100) than normal rats. On the other hand, during 0.225 per cent saline diuresis, fractional free water clearance (CH2O/GFR times 100) was normal over a wide range of fractional urine flow (V/GFR times 100), indicating intact function of the ascending limb of the loop of Henle. The intravenous infusion of
vasopressin
(VP) or dibutyryl cyclic-adenosine monophosphate (dcAMP) to Li+-treated rats resulted in a modest rise in Uosm. and a reduction in V/GFR times 100 and CH2O/GFR times 100. Although the response to VP appeared earlier than that to dibutyryl cyclic-
AMP
, the magnitude of the changes in Uosm., V/GFR times 100, and CH2O/GFR times 100 was eventually the same with both substances. Comparison between normal and Li+-treated rats revealed that the response to both VP and dibutyryl cyclic-
AMP
was blunted, albeit to a greater extent in the former. Inhibition by Li+ of adenylate cyclase will only partially explain the present data. Impairment in the release of endogenous VP or a block distal to the formation of cyclic-
AMP
must have played a role. In view of a normal diluting capacity and the increase in the excretion of phosphate and uric acid, it is suggested that Li+, when administered chronically in the present doses, inhibits proximal tubular reabsorption.
...
PMID:Renal effects of lithium administration in rats: alterations in water and electrolyte metabolism and the response to vasopressin and cyclic-adenosine monophosphate during prolonged administration. 16 79
Cadmium, 10(-3) mol/l on the mucosal or 10(-5) mol/l on the serosal side of the toad urinary bladder, inhibits the hydro-osmotic effect of
vasopressin
. This inhibition is irreversible. The osmotic transfer of water in the absence of
vasopressin
was unaffected by the presence of the Cd2+. The hydro-osmotic response to cyclic
AMP
was also reduced by the Cd2+, but the response due to hypertonicity of the serosal bathing solution was unaffected. The short-circuit current (reflecting active transmural Na+ transport) was inhibited by 10(-3) mol Cd2+/l on the serosa, but was increased by 10(-3) mol/l at the mucosa or 10(-4) mol/l at the serosa. The natriferic response of the bladder to
vasopressin
was unaffected when Cd2+ was present under conditions that inhibited the hydro-osmotic response, further emphasizing that separate effector mechamisms may be involved for each effect.
...
PMID:Effects of cadmium of the hydro-osmotic and natriferic responses to the toad bladder to vasopressin. 17 Mar 55
Recent data on the effects of neurohypophysial peptides at the cellular level are discussed with respect to the two basic processes involved in peptide hormone action--i.e., specific recognition of the information contained in the hormonal molecule and the transformation of this information into a stimulus leading to the final biological response. Four main aspects of this general problem are considered. A. Hormone-Receptor Interaction: Recent contributions in this field concern partial analysis of the three-dimensional conformation of oxytocin and
vasopressin
moleculal cells of the mammalian kidney. Conformational analysis of oxytocin and
vasopressin
molecules leads to the conclusion that, in solution, these peptides probably have a compact and highly stabilized three-dimensional configuration. Models have been proposed that provide a valuable clue to the interpretation of structure-activity relationships among natural hormones and many structural analogues. Binding studies with tritiated oxytocin and
vasopressin
have permitted determination of the kinetic parameters of hormone-receptor interaction in amphibian epithelial cells and mammalian kidney. B. Stimulus Generation: The nature of the primary stimulus generated by hormone-receptor interaction is still unknown. In the epithelial target cells of the amphibian skin and bladder and of the mammalian kidney, one of the first consequences of hormone-receptor interaction is the activation of membrane-bound adenylate cyclase. Analysis of the correlations between hormonal binding and adenylate cyclase activation suggests that activation is a function of receptor occupation rather than of the number of hormonal molecules interacting with the receptor per unit of time. On medullary adenylate cyclase of pig kidney, the relation between receptor occupancy and enzyme activation was found to be complex and nonlinear. The effects of several agents (calcium, nucleotides) on receptor occupancy and adenylate cyclase activation have been described. In mammalian uterus and other smooth muscle target cells, there is no evidence for direct involvement of cyclic
AMP
in the contractile response to oxytocin and other neurohypophysial peptides.
...
PMID:Stimulus-response coupling in neurohypophysial peptide target cells. 17 91
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>